Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2012


Adaptive Designs in Clinical Drug Development

26 Mar 2012 - 27 Mar 2012 - London, UK



Bookmark and Share


‘Buying in’ to adaptive design trials: strategies and methods for implementing successful adaptive design studies Monday 26th & Tuesday 27th March 2012, Grange Holborn, London
SMi are proud to present the 6th Annual Adaptive Designs in Clinical Drug Development conference, following on from SMi’s previous highly successful Adaptive Designs events and offers the opportunity to keep up-to-date with the latest challenges and solutions essential for successful and cost-effective adaptive clinical trials.
In recent years, the use of adaptive design in clinical trials has been considered an efficient and optimal way of designing clinical trials.  Adaptive design has gradually evolved from a novel idea into a standard norm in the pharmaceutical industry. This new clinical paradigm could change the way traditional clinical trials, with their restrictive guidance, are run today.
With more flexibility, faster development timelines and significant monetary savings, an adaptive design trial is the way forward.
The conference will address adaptive clinical trials for rare disease medicine development. The agenda will not only tackle issues surrounding effective management of your adaptive design in clinical trials but the increasing use of Bayesian modelling and using adaptive designs in early clinical trials. As adaptive designs are recently gradually evolving from a novel idea into a standard norm in the pharmaceuticals industry, industry leaders are asking themselves whether to adapt or not to adapt.

Key Reasons to attend Adaptive Designs in Clinical Drug Development;
•    Learn how to maximise the benefits of an adaptive design through effective management
•    Develop your knowledge of the adaptive designs. From start to end, it is important to know everything about adaptive clinical trials to gain maximum advantage.
•    Understand the challenges of the high-density biomarker adaptive trial.
•    Discover what the future holds in this rapidly evolving market and the impact of new regulation and technology.
•    Improve your clinical trials in early phases to reduce costs and time.
•    Evolve your understanding of current technologies to protect trial integrity, reduce operational bias and build regulatory confidence.
•    Network with key industry professionals
Visit the website to register: http://www.smi-online.co.uk/2012adaptivedesigns9.asp
Alternatively or contact Shilan Chandi on: +44 (0)20 7827 6738 e-mail: schandi@smi-online.co.uk



Further information
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!